Search Results - "Kühnöl, Caspar"

  • Showing 1 - 18 results of 18
Refine Results
  1. 1

    Musashi1 enhances chemotherapy resistance of pediatric glioblastoma cells in vitro by Pötschke, Rebecca, Gielen, Gerrit, Pietsch, Torsten, Kramm, Christof, Klusmann, Jan-Henning, Hüttelmaier, Stefan, Kühnöl, Caspar D.

    Published in Pediatric research (01-03-2020)
    “…Background Glioblastoma (GBM) is the most aggressive form of glioma in adults and children and is associated with very poor prognosis. Pediatric tumors are…”
    Get full text
    Journal Article
  2. 2

    Use of nonacog beta pegol during surgery in persons with hemophilia B: a case series by Phua, Chai W., Matino, Davide, Kühnöl, Caspar D., Hegemann, Inga, Matsushita, Tadashi

    “…Hemophilia B is a coagulation disorder that puts patients at an increased risk of bleeding. Factor (F) IX replacement therapy is traditionally used in such…”
    Get full text
    Journal Article
  3. 3

    Occurrence of high‐grade glioma in Noonan syndrome: Report of two cases by El‐Ayadi, Moatasem, Ansari, Marc, Kühnöl, Caspar D., Bendel, Anne, Sturm, Dominik, Pietsch, Torsten, Kramm, Christof M., Bueren, André O.

    Published in Pediatric blood & cancer (01-05-2019)
    “…Noonan syndrome (NS) is an autosomal dominant disorder commonly caused by PTPN11 germline mutations. Patients are characterized by short stature, congenital…”
    Get full text
    Journal Article
  4. 4

    MSI1 Promotes the Expression of the GBM Stem Cell Marker CD44 by Impairing miRNA-Dependent Degradation by Pötschke, Rebecca, Haase, Jacob, Glaß, Markus, Simmermacher, Sebastian, Misiak, Claudia, Penalva, Luiz O F, Kühnöl, Caspar D, Hüttelmaier, Stefan

    Published in Cancers (05-12-2020)
    “…The stem cell marker Musashi1 (MSI1) is highly expressed during neurogenesis and in glioblastoma (GBM). MSI1 promotes self-renewal and impairs differentiation…”
    Get full text
    Journal Article
  5. 5

    Lenalidomide in an in vitro Dendritic Cell Model for Malignant Gliomas by Kühnöl, Caspar D, Staege, Martin S, Kramm, Christof M

    Published in Anti-cancer agents in medicinal chemistry (01-01-2016)
    “…Malignant gliomas are tumors with a very unfavorable prognosis. They are characterized by rapid proliferation and invasion in the surrounding healthy tissue…”
    Get more information
    Journal Article
  6. 6

    Snail homolog 1 is involved in epithelial-mesenchymal transition-like processes in human glioblastoma cells by Kühnöl, Caspar D, Würfel, Carina, Staege, Martin S, Kramm, Christof

    Published in Oncology letters (01-05-2017)
    “…Despite advancements in neurosurgery, chemotherapy and radiation therapy, the outcome of patients with glioblastoma remains poor. The migration of tumor cells…”
    Get full text
    Journal Article
  7. 7

    The use of Do-Not-Resuscitate-Order equivalents in pediatric palliative care medicine in Germany by Waske, Anja, Kühnöl, Caspar D, Kramm, Christof M

    Published in Annals of palliative medicine (01-04-2019)
    “…In the last years, the structure of Pediatric Palliative Care in Germany has developed more and more. Since 2007, there is a legal claim for a specialized…”
    Get full text
    Journal Article
  8. 8

    Immunostimulation by OX40 Ligand Transgenic Ewing Sarcoma Cells by Reuter, Dajana, Staege, Martin S, Kühnöl, Caspar D, Föll, Jürgen

    Published in Frontiers in oncology (27-10-2015)
    “…Interleukin-2 (IL-2) transgenic Ewing sarcoma cells can induce tumor specific T and NK cell responses and reduce tumor growth in vivo and in vitro…”
    Get full text
    Journal Article
  9. 9

    Indoleamine-2,3-dioxygenase in an immunotherapy model for Ewing sarcoma by Max, Daniela, Kühnöl, Caspar D, Burdach, Stefan, Niu, Liguo, Staege, Martin S, Föll, Jürgen L

    Published in Anticancer research (01-11-2014)
    “…Interleukin-2 (IL2) transgenic Ewing sarcoma cells reduce tumor growth in vivo and in vitro. In the present study we analyzed the expression of immune…”
    Get full text
    Journal Article
  10. 10

    Radiotherapy of brain metastases from breast cancer: Treatment results and prognostic factors by KÜHNÖL, JULIA, KÜHNÖL, CASPAR, VORDERMARK, DIRK

    Published in Oncology letters (01-05-2016)
    “…Brain metastases (BM) from breast cancer are associated with high morbidity and a poor prognosis. The aim of this study was to analyse the role of radiotherapy…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Using simulated patients to test competency in child protection medicine in the third section of the medical examination by Steglich, Jonas, Hempel, Linn, Jaspers, Susanna, Stoevesandt, Dietrich, Weber, Marko, Kunze, Christian, Weihrauch-Blüher, Susann, Kühnöl, Caspar, Woydt, Lina

    Published in Monatsschrift Kinderheilkunde (28-12-2022)
    “…During the COVID-19 pandemic, the third section of the medical examination could be performed with simulation patients. Simulations enable standardized…”
    Get full text
    Journal Article
  13. 13

    EPID-18. NOONAN SYNDROME CAN BE ASSOCIATED WITH HIGH GRADE GLIOMA; A REPORT OF TWO CASES by El-Ayadi, Moatasem, Ansari, Marc, Kühnöl, Caspar, Bendel, Anne, Sturm, Dominik, Pietsch, Torsten, Kramm, Christof, von Bueren, André

    Published in Neuro-oncology (Charlottesville, Va.) (06-11-2017)
    “…Noonan syndrome (NS), an autosomal dominant disorder, is characterized by short stature, congenital heart defects, developmental delay, and facial dysmorphism…”
    Get full text
    Journal Article
  14. 14

    CD137 stimulation and p38 MAPK inhibition improve reactivity in an in vitro model of glioblastoma immunotherapy by Kühnöl, Caspar, Herbarth, Monique, Föll, Jürgen, Staege, Martin S., Kramm, Christof

    Published in Cancer Immunology, Immunotherapy (01-12-2013)
    “…Dendritic cell vaccination has become an interesting option for cancer immunotherapy. Tumor-lysate-pulsed dendritic cells (DC) can prime naïve T cells and…”
    Get full text
    Journal Article
  15. 15

    Einsatz von Simulationspersonen zur Prüfung von Handlungskompetenz im Bereich der Kinderschutzmedizin im Dritten Abschnitt der Ärztlichen Prüfung by Steglich, Jonas, Hempel, Linn, Jaspers, Susanna, Stoevesandt, Dietrich, Weber, Marko, Kunze, Christian, Weihrauch-Blüher, Susann, Kühnöl, Caspar, Woydt, Lina

    Published in Monatsschrift Kinderheilkunde (28-12-2022)
    “…Zusammenfassung In der COVID-19-Pandemie war die Durchführung des Dritten Abschnitts der Ärztlichen Prüfung mit Simulationspersonen möglich. Simulationen…”
    Get full text
    Journal Article
  16. 16

    Prognostic Biomarkers for Hodgkin Lymphoma by Staege, Martin S., Kewitz, Stefanie, Bernig, Toralf, Kühnöl, Caspar, Mauz-Körholz, Christine

    Published in Pediatric hematology and oncology (03-10-2015)
    “…The prognosis of patients with classical Hodgkin lymphoma following chemo- and radiotherapy has been excellent during the last 4 decades. However, the…”
    Get full text
    Journal Article
  17. 17

    Use of nonacog beta pegol during surgery in persons with hemophilia B: a case series by Phua, Chai W, Matino, Davide, Kühnöl, Caspar D, Hegemann, Inga, Matsushita, Tadashi

    “…BackgroundHemophilia B is a coagulation disorder that puts patients at an increased risk of bleeding. Factor (F) IX replacement therapy is traditionally used…”
    Get full text
    Report
  18. 18

    Immuno-stimulation by OX40 ligand transgenic Ewing sarcoma cells by Dajana eReuter, Martin Sebastian Staege, Caspar David Kühnöl, Juergen eFoell

    Published in Frontiers in oncology (01-10-2015)
    “…Interleukin-2 (IL-2) transgenic Ewing sarcoma cells can induce tumor specific T and NK cell responses and reduce tumor growth in vivo and in vitro…”
    Get full text
    Journal Article